AI in drug discovery market size to $3,932.87 million by 2027

June 13, 2020
AI in drug discovery market size to $3,932.87 million by 2027

AI in drug discovery market size to $3,932.87 million by 2027 as per report by Data Bridge Market Research. Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 growing at a CAGR of 40.5% in the forecast period of 2020 to 2027

AI in drug discovery market size to $3,932.87 million by 2027

Increasing need to reduce cost and drug discovery along with reduce time, growth of pharmaceutical industries by collaborations with other industries, adoption of cloud based services and applications, delay in patent expiry are some of the factors that will enhance the growth of artificial intelligence (AI) in drug discovery market in the forecast period of 2020-2027. On the other hand, expansion of biotechnology industries will further create new and ample opportunities for the growth of artificial intelligence (AI) in drug discovery market in the above mentioned forecast period

Unavailability of skilled labour and lack of data sets are acting as market challenges for the growth of artificial intelligence (AI) in drug discovery

Which countries are covered in the Report?

The countries covered in the artificial intelligence (AI) in drug discovery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Who are major players in drug discovery market?

The major players covered in the artificial intelligence (AI) in drug discovery market report are Microsoft, NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI   Ltd, Exscientia, Cyclica Inc., Numerate, NuMedii, Inc., Envisagenics., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. 

Read about the summary of report at Data Bridge Market Reasearch

Click here to read more such interesting news.